E PROCESS MED tackles one of the 10 public health challenges announced by WHO

We are pleased to announce that our research project D&S-AI, in collaboration with the Biomedical Research and Innovation Institute of Cádiz INiBICA, has achieved exceptional results in the early and accurate detection of COVID-19 using artificial intelligence.   Key Achievements: We developed a predictive algorithm that combines an optimized questionnaire and antigen tests. We achieved…

VRPharma: virtual reality in the service of healthcare

Cruces University Hospital has recently adopted a Virtual Reality solution from one of our partners, VRPharma. These virtual reality glasses aim to reduce the fear and anxiety of children undergoing blood draws, among other services. This innovative approach allows young patients to immerse themselves in relaxing virtual environments, significantly improving their comfort and overall experience…

ACESABIO, the Alliance of Spanish Health and Biosciences Clusters, meets at the Galicia Biodays.

From left to right: Idoia Muñoz (Basque Health Cluster), Jesús Agüero (BIOVAL), Iván Rarís Filgueira (Cluster Saúde de Galicia, CSG), Ion Arocena (ASEBIO), Loli Pereiro (BIOGA), Alberto Nozal (AraHealth), Javier Selva (CataloniaBio &HealthTech), Zara Pons (BIOIB).   Betseen the 12 and 13 of June, members of ACESABIO met in Vigo at the Galicia Biodays event…

RPK Group presents its division aimed at the medical device market: RPK Medical

Vitoria-Gasteiz – June 10, 2024 – RPK Group, a global leader in engineering and manufacturing of springs, metal stamping and bending components, and high-complexity assemblies, celebrates its 50th anniversary by announcing the creation of RPK Medical, a new brand focused on the medical sector. This new division is born with the firm purpose of surpassing…

Visit of the Provincial Deputy for Economic Development and Innovation of Alava to Liof Pharma

Saray Zárate, the current Deputy for Economic Development and Innovation of Álava, and Ander Larrinaga, Director of Economic Development and Innovation of the Álava Provincial Council, visited Liof Pharma’s facilities last Monday, June 17, to learn more about the Liof Pharma project. During this visit, they had the opportunity to explore Liof Pharma’s capabilities and…

The member companies of the Basque Health Cluster have added 1,500 new jobs in the last year

The member companies and organisations of the Basque Health Cluster (BHC) have added up to 1,500 people to their workforces in the last year, bringing the total number of professionals to 11,500. If we include the research staff linked to Biohealth and Biosciences at Technology Centres, Research Centres and Universities, the Basque Country now has…

GAIKER launches its new website

The new website contains more complete information, is secure, accessible, user-friendly and can be viewed correctly on all devices and browsers. Zamudio, 06 June 2024. GAIKER Technology Centre, a member of the Basque Research & Technology Alliance, BRTA, reaffirms its commitment to continuous improvement, innovation and creativity with the launch of a new website: https://www.gaiker.es.…

VIVEbiotech receives the “New Company of Gipuzkoa 2024” award from ADEGI

VIVEbiotech has been awarded the prize “New Company of Gipuzkoa 2024” by ADEGI, Business Association of Gipuzkoa. During the ceremony that took place last Thursday at the beautiful FabrikaNCE headquarters as part of the General Assembly and Company Day 2024, Gurutz Linazasoro (Executive President), Jon Alberdi (General Manager) and Natalia Elizalde (Business Development Director) received…

IRISBOND closes a crowdlending round on Bolsa Social after reaching its maximum goal in one month.

The round has allowed to raise 400,000 euros, which will be destined for the Spanish technological company to consolidate its eye-tracking technology, which has recently been included in the catalog of products authorized by the National Health System. In addition, the company will be able to meet the increased demand for its Augmentative and Alternative…

IDIMO: Research on New Advanced Medical Devices for Enhanced Immune and Infection Control and Monitoring

IDIMO, an acronym for ‘Investigation into New Advanced Medical Devices for Enhanced Control and Monitoring of Immune Response and Infections’, is a leading collaborative project in the research and development of innovative medical devices to strengthen the control and monitoring of immune response and associated infections. Under the leadership of I+MEDS. COOP, this ambitious project…